ArticleSensors (Basel, Switzerland)2025
FALS-YOLO: An Efficient and Lightweight Method for Automatic Brain Tumor Detection and Segmentation.
Article in Sensors (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- An intelligent context-aware facial emotion recognition system for hearing-impaired individuals using large language models and neural network-based feature fusion.Scientific reports · 2026Article
- High-accuracy brain tumor detection method based on deep learning.Scientific reports · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
Brain tumors are highly malignant diseases that severely threaten the nervous system and patients' lives. MRI is a core technology for brain tumor diagnosis and treatment due to its high resolution and non-invasiveness. However, existing YOLO-based models face challenges in brain tumor MRI image detection and segmentation, such as insufficient multi-scale feature extraction and high computational resource consumption. This paper proposes an improved lightweight brain tumor detection and instance segmentation model named FALS-YOLO, based on YOLOv8n-Seg and integrating three key modules: FLRDown, AdaSimAM, and LSCSHN. FLRDown enhances multi-scale tumor perception, AdaSimAM suppresses noise and improves feature fusion, and LSCSHN achieves high-precision segmentation with reduced parameters and computational burden. Experiments on the tumor-otak dataset show that FALS-YOLO achieves Precision (B) of 0.892, Recall (B) of 0.858, mAP@0.5 (B) of 0.912 in detection, and Precision (M) of 0.899, Recall (M) of 0.863, mAP@0.5 (M) of 0.917 in segmentation, outperforming YOLOv5n-Seg, YOLOv8n-Seg, YOLOv9s-Seg, YOLOv10n-Seg and YOLOv11n-Seg. Compared with YOLOv8n-Seg, FALS-YOLO reduces parameters by 31.95%, computational amount by 20.00%, and model size by 32.31%. It provides an efficient, accurate and practical solution for the automatic detection and instance segmentation of brain tumors in resource-limited environments.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.